Maxcyte Inc (MXCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,034 | -22,618 | -10,261 | -41,055 | -30,458 |
| Depreciation Amortization | 1,049 | 561 | 212 | -1,927 | -1,794 |
| Accounts receivable | -3,649 | -1,077 | -839 | 1,226 | 1,348 |
| Other Working Capital | -7,586 | -9,480 | -7,694 | -751 | 960 |
| Other Operating Activity | 13,499 | 8,351 | 4,171 | 14,897 | 10,155 |
| Operating Cash Flow | $-31,721 | $-24,263 | $-14,411 | $-27,610 | $-19,789 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 19,569 | 14,077 | 11,955 | 8,583 | 10,101 |
| PPE Investments | -1,537 | -1,237 | -653 | -1,651 | -1,504 |
| Net Acquisitions | -1,773 | -1,773 | -1,773 | N/A | N/A |
| Investing Cash Flow | $16,259 | $11,067 | $9,529 | $6,932 | $8,597 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 551 | 537 | 383 | 2,056 | 1,644 |
| Financing Cash Flow | $551 | $537 | $383 | $2,056 | $1,644 |
| Beginning Cash Position | 27,884 | 27,884 | 27,884 | 46,506 | 46,506 |
| End Cash Position | 12,973 | 15,225 | 23,385 | 27,884 | 36,958 |
| Net Cash Flow | $-14,911 | $-12,659 | $-4,499 | $-18,622 | $-9,548 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,721 | -24,263 | -14,411 | -27,610 | -19,789 |
| Capital Expenditure | -1,537 | -1,237 | -653 | -1,651 | -1,504 |
| Free Cash Flow | -33,258 | -25,500 | -15,064 | -29,261 | -21,293 |